http://www.icvec.com/Non-viral drug delivery technology based on cationic liposomes, under clinical development for vector systems on license from Imperial College, London, UK.Biopharmaceuticals > Delivery SystemsFor detailed information visit the website, please...
waiting for hand_moderation
Focuses on the application of its bioconjugation platform in various therapeutic areas such as cancer, pain, HIV, diabetes and thrombosis. Includes technology overview, research pipeline, partnerships, investment news, profiles of key staff in Montreal, Canada.
Manufactures custom peptides, protein conjugates and liposomes. Includes technology overview, applications, request forms and contacts in North West England.
Non-viral drug delivery technology based on cationic liposomes, under clinical development for vector systems on license from Imperial College, London, UK.
Joining mailing list will entitle you
to receive occasional emails informing you of news and
updates to the site and any special offers that may be
of interest to you.